Drug pricing debates: Can we quantify what a life’s worth?

Drug pricing debates: Can we quantify what a life’s worth?

celebrex pills

Harvard startup promises progress in treating deadly sepsis

http://upstart.bizjournals.com/news/technology/2015/10/09/harvard-startup-promises-progress-in-treating.html?ana=e_ptl_hc&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1444506368&page=all

Sepsis, Wyss Institute

In the Wyss Institute’s approach to sepsis therapy, the pathogen-binding FcMBL protein is tethered to the interior of hollow fibers within the cartridge. This cartridge can be plugged into a dialysis-like extracorporeal circuit through which the blood from patients with sepsis could be run and cleansed.

Washington state’s life sciences companies shatter records with more than $3B in deals

http://www.bizjournals.com/seattle/blog/health-care-inc/2015/10/washington-states-life-sciences-companies-shatter.html?ana=e_ptl_hc&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1444506012

There has been more than $3 billion worth of money and deals in the life science industry so far this year.

Juno CEO: ‘Can our own T-cells eat a solid tumor? The answer is yes’

http://www.bizjournals.com/seattle/blog/health-care-inc/2015/07/juno-ceo-can-our-own-t-cells-eat-a-solid-tumor-the.html?ana=e_vert_st_20150727

Juno Therapeutics CEO Hans Bishop spoke on CNBC Friday morning.

Juno CEO Hans Bishop went on CNBC Friday morning to talk about how immunotherapy works at a cellular level, and made it sound even more surreal. “If you ask the question, ‘Can our own T-cells eat a solid tumor?’ the answer is yes,” Bishop said.

GlaxoSmithKline dropping $95M to create research institute

http://www.bizjournals.com/philadelphia/blog/health-care/2015/06/glaxosmithkline-gsk-genome-research-institute.html?ana=e_du_pub&s=article_du&ed=2015-06-17&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1434642965

GlaxoSmithKline's building at the Philadelphia Navy Yard Corporate Center

Cancer-smelling dogs can take a break. E-nose technology is effectively sniffing out diseases

Cancer-smelling dogs can take a break. E-nose technology is effectively sniffing out diseases

dog nose

Theranos’ new deal with billionaire Carlos Slim may take it another level

http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/06/theranos-carlos-slim-foundation-mexico-casalud.html?ana=e_du_pub&s=article_du&ed=2015-06-23&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1435169523

Elizabeth Holmes started Theranos in 2003.

Elizabeth Holmes started Theranos in 2003.

Novartis on digitizing medicine in an aging world

http://www.mckinsey.com/insights/leading_in_the_21st_century/Novartis_on_digitizing_medicine_in_an_aging_world?cid=ceointerview-eml-alt-mip-mck-oth-1506

Novartis on digitizing medicine in an aging world

CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.

Opinion: Investors should check up on health-care stocks

http://www.marketwatch.com/story/investors-should-check-up-on-health-care-stocks-2015-06-19